Literature DB >> 5922092

The preparation and properties of alexinated intermediates that react with conglutinin. I. Guinea-pig complement.

P J Lachmann, R Liske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5922092      PMCID： PMC1423791     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  7 in total

1.  A comparison of some properties of bovine conglutinin with those of rabbit immuno-conglutinin.

Authors:  P J LACHMANN
Journal:  Immunology       Date:  1962-11       Impact factor: 7.397

2.  Isolation and description of proteins related to the human complement system.

Authors:  H J MULLER-EBERHARD
Journal:  Acta Soc Med Ups       Date:  1961

3.  Multiple nature of the third component of guinea-pig complement. II. Separation and description of two additional factors beta and d; preparation and characterization of four intermediate products.

Authors:  H J Wellensiek; P G Klein
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

4.  Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b, and c, essential for haemolysis.

Authors:  P G Klein; H J Wellensiek
Journal:  Immunology       Date:  1965-06       Impact factor: 7.397

5.  A possible homeostatic mechanism in complement fixation: inhibition of the activity of fixed C'1 by the fixation of C'3a.

Authors:  P J Lachmann
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

6.  A sedimentation pattern technique for measuring conglutination: its application to demonstrating immunoconglutinins to C'4.

Authors:  P J Lachmann
Journal:  Immunology       Date:  1966-09       Impact factor: 7.397

7.  COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.

Authors:  K NISHIOKA; W D LINSCOTT
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307
  7 in total
  10 in total

1.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

2.  Immunoconglutinins of different immunoglobulin classes demonstrated by the antiglobulin reaction.

Authors:  P M Henson
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

3.  The adherence of leucocytes and platelets induced by fixed IgG antibody or complement.

Authors:  P M Henson
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

4.  Effect of the cationic environment on immune haemolysis of high potassium and low potassium sheep erythrocytes.

Authors:  M M De Bracco; A P Dalmasso
Journal:  Immunology       Date:  1969-10       Impact factor: 7.397

5.  Immunoglobulin studies in serum of patients with American trypanosomiasis (Chagas' disease).

Authors:  R Lelchuk; A P Dalmasso; C L Inglesini; M Alvarez; J A Cerisola
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

6.  The preparation and properties of alexinated intermediates that react with conglutinin. II. Equine, rabbit and human complement.

Authors:  P J Lachmann; R Liske
Journal:  Immunology       Date:  1966-09       Impact factor: 7.397

7.  A sedimentation pattern technique for measuring conglutination: its application to demonstrating immunoconglutinins to C'4.

Authors:  P J Lachmann
Journal:  Immunology       Date:  1966-09       Impact factor: 7.397

8.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.

Authors:  R C Gupta; E M Tan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

10.  The opsonic fragment of the third component of human complement (C3).

Authors:  T P Stossel; R J Field; J D Gitlin; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.